• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (55030778)   Find a Category (126)   Find a Journal (6150)   Find a Scholar (3940)   Find an Academic Assistant (17)
Find an Article PDF (4591707)   Today's Articles (1498)   Subscriber (49313)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
Year Published
Show more   Refine
For: Santamaría G, Avila S, Moneo V, Cuevas C, García-Fernández LF, Galmarini CM. Abstract 2520: Synergistic combination of lurbinectedin and PARP inhibitors in breast cancer tumor cell lines. Cancer Res 2015. [DOI: 10.1158/1538-7445.am2015-2520] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Number Cited by Other Article(s)
1
Phase I study of lurbinectedin, a synthetic tetrahydroisoquinoline that inhibits activated transcription, induces DNA single- and double-strand breaks, on a weekly × 2 every-3-week schedule. Invest New Drugs 2017;35:471-477. [DOI: 10.1007/s10637-017-0427-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2016] [Accepted: 01/10/2017] [Indexed: 11/29/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA